ASH 2011: Dr. Lentzsch - Combination of Bendamustine, Lenalidomide, and Dexamethasone (BLD) in Patients with Refractory or Relapsed Multiple Myeloma Is Safe and Highly Effective: Results of Phase I/II Open-Label, Dose Escalation Study
Suzanne Lentzsch, MD, PhD
University of Pittsburgh School of Medicine and Cancer Institute
Pittsburgh, Pennsylvania, USA
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.